Construction, expression and functional analysis of anti-B7-H4-scFv-CH3 recombinant antibody
- 10 July 2018
- journal article
- research article
- Published by Springer Nature in Journal of Biosciences
- Vol. 43 (4) , 661-671
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Host B7-H4 Regulates Antitumor T Cell Responses through Inhibition of Myeloid-Derived Suppressor Cells in a 4T1 Tumor Transplantation ModelThe Journal of Immunology, 2013
- Fine tuning the immune response through B7‐H3 and B7‐H4Immunological Reviews, 2009
- B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulationCancer Letters, 2008
- Inhibitory B7-family molecules in the tumour microenvironmentNature Reviews Immunology, 2008
- Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapyCancer Letters, 2006
- The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformationExperimental Cell Research, 2005
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- An expressed pseudogene regulates the messenger-RNA stability of its homologous coding geneNature, 2003
- CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation ModelImmunological Reviews, 1996
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991